Skip to main content

RIVASTIGMINE TARTRATE

NDC 33342-091 · Macleods Pharmaceuticals Limited

Generic nameRIVASTIGMINE TARTRATE
Dosage formCAPSULE
RouteORAL
Active ingredient(s)RIVASTIGMINE TARTRATE
Strength4.5 mg/1
Pharmacologic classCholinesterase Inhibitor [EPC], Cholinesterase Inhibitors [MoA]
Marketing categoryANDA

Packages

33342-091-06 — 3 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-091-06) / 10 CAPSULE in 1 BLISTER PACK

33342-091-09 — 60 CAPSULE in 1 BOTTLE (33342-091-09)

33342-091-12 — 10 BLISTER PACK in 1 BOX, UNIT-DOSE (33342-091-12) / 10 CAPSULE in 1 BLISTER PACK

33342-091-15 — 500 CAPSULE in 1 BOTTLE (33342-091-15)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0904-7107 — Rivastigmine Tartrate, 33342-089 — RIVASTIGMINE TARTRATE, 33342-090 — RIVASTIGMINE TARTRATE, 33342-092 — RIVASTIGMINE TARTRATE, 46708-063 — Rivastigmine Tartrate, 46708-064 — Rivastigmine Tartrate, 46708-065 — Rivastigmine Tartrate, 46708-066 — Rivastigmine Tartrate, 55111-352 — Rivastigmine Tartrate, 55111-353 — Rivastigmine Tartrate, 55111-354 — Rivastigmine Tartrate, 55111-355 — Rivastigmine Tartrate, 60687-777 — Rivastigmine Tartrate, 62135-900 — Rivastigmine Tartrate, 62135-901 — Rivastigmine Tartrate, 62135-902 — Rivastigmine Tartrate, 62135-903 — Rivastigmine Tartrate, 62332-063 — Rivastigmine Tartrate, 62332-064 — Rivastigmine Tartrate, 62332-065 — Rivastigmine Tartrate, +21 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels